Figure 3.
Figure 3. (A) Relapse-free survival of the three MRD-based risk groups of children treated for ALL according to protocols of the International BFM Study Group. The three risk groups were defined by combined MRD information at the end of induction treatment and before consolidation treatment (see 30 for details). / (B) Relapse-free survival according to the qualitative (presence or absence) and quantitative detection of MRD after the completion of induction therapy in EORTC trial 58881 (with courtesy to Dr. H. Cavé and Prof. E. Vilmer).32,36

(A) Relapse-free survival of the three MRD-based risk groups of children treated for ALL according to protocols of the International BFM Study Group. The three risk groups were defined by combined MRD information at the end of induction treatment and before consolidation treatment (see30 for details).

(B) Relapse-free survival according to the qualitative (presence or absence) and quantitative detection of MRD after the completion of induction therapy in EORTC trial 58881 (with courtesy to Dr. H. Cavé and Prof. E. Vilmer).32,36 

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal